110 related articles for article (PubMed ID: 9713959)
1. Primary blasts from infants with acute lymphoblastic leukemia cause overt leukemia in SCID mice.
Uckun FM; Waurzyniak BJ; Sensel MG; Chelstrom L; Crotty ML; Gaynon PS; Reaman GH
Leuk Lymphoma; 1998 Jul; 30(3-4):269-77. PubMed ID: 9713959
[TBL] [Abstract][Full Text] [Related]
2. Human t(1;19)(q23;p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency.
Uckun FM; Downing JR; Gunther R; Chelstrom LM; Finnegan D; Land VJ; Borowitz MJ; Carroll AJ; Crist WM
Blood; 1993 Jun; 81(11):3052-62. PubMed ID: 8098968
[TBL] [Abstract][Full Text] [Related]
3. In vivo anti-leukemic efficacy of anti-CD7-pokeweed antiviral protein immunotoxin against human T-lineage acute lymphoblastic leukemia/lymphoma in mice with severe combined immunodeficiency.
Gunther R; Chelstrom LM; Finnegan D; Tuel-Ahlgren L; Irvin JD; Myers DE; Uckun FM
Leukemia; 1993 Feb; 7(2):298-309. PubMed ID: 7678882
[TBL] [Abstract][Full Text] [Related]
4. Leukemic cell growth in SCID mice as a predictor of relapse in high-risk B-lineage acute lymphoblastic leukemia.
Uckun FM; Sather H; Reaman G; Shuster J; Land V; Trigg M; Gunther R; Chelstrom L; Bleyer A; Gaynon P
Blood; 1995 Feb; 85(4):873-8. PubMed ID: 7849309
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of B-lineage leukemic cell growth in SCID mice: a Children's Cancer Group Study.
Uckun FM; Sather HN; Waurzyniak BJ; Sensel MG; Chelstrom L; Ek O; Sarquis MB; Nachman J; Bostrom B; Reaman GH; Gaynon PS
Leuk Lymphoma; 1998 Aug; 30(5-6):503-14. PubMed ID: 9711913
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of T-lineage leukemic cell growth in SCID mice: a Children's Cancer Group study.
Uckun FM; Waurzyniak BJ; Sather HN; Sensel MG; Chelstrom L; Nachman J; Gaynon PS; Bostrom B; Ek O; Sarquis M; Steinherz PG; Reaman GH
Leuk Lymphoma; 1999 Feb; 32(5-6):475-87. PubMed ID: 10048420
[TBL] [Abstract][Full Text] [Related]
7. Human t(4;11)(q21;q23) acute lymphoblastic leukemia in mice with severe combined immunodeficiency.
Uckun FM; Downing JR; Chelstrom LM; Gunther R; Ryan M; Simon J; Carroll AJ; Tuel-Ahlgren L; Crist WM
Blood; 1994 Aug; 84(3):859-65. PubMed ID: 8043867
[TBL] [Abstract][Full Text] [Related]
8. An animal model for human cellular immunotherapy: specific eradication of human acute lymphoblastic leukemia by cytotoxic T lymphocytes in NOD/scid mice.
Nijmeijer BA; Willemze R; Falkenburg JH
Blood; 2002 Jul; 100(2):654-60. PubMed ID: 12091361
[TBL] [Abstract][Full Text] [Related]
9. A human acute lymphoblastic leukemia line with the T(4;11) translocation as a model of minimal residual disease in SCID mice.
Gobbi A; Di Berardino C; Scanziani E; Garofalo A; Rivolta A; Fontana G; Rambaldi A; Giavazzi R; Biondi A
Leuk Res; 1997; 21(11-12):1107-14. PubMed ID: 9444945
[TBL] [Abstract][Full Text] [Related]
10. Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group.
Reaman GH; Sposto R; Sensel MG; Lange BJ; Feusner JH; Heerema NA; Leonard M; Holmes EJ; Sather HN; Pendergrass TW; Johnstone HS; O'Brien RT; Steinherz PG; Zeltzer PM; Gaynon PS; Trigg ME; Uckun FM
J Clin Oncol; 1999 Feb; 17(2):445-55. PubMed ID: 10080584
[TBL] [Abstract][Full Text] [Related]
11. Selective homing of human leukemic B-cell precursors to specific lymphohematopoietic microenvironments in SCID mice: a role for the beta 1 integrin family surface adhesion molecules VLA-4 and VLA-5.
Messinger Y; Chelstrom L; Gunther R; Uckun FM
Leuk Lymphoma; 1996 Sep; 23(1-2):61-9. PubMed ID: 9021687
[TBL] [Abstract][Full Text] [Related]
12. Good engraftment of B-cell precursor ALL in NOD-SCID mice.
Baersch G; Möllers T; Hötte A; Dockhorn-Dworniczak B; Rübe C; Ritter J; Jürgens H; Vormoor J
Klin Padiatr; 1997; 209(4):178-85. PubMed ID: 9293448
[TBL] [Abstract][Full Text] [Related]
13. Growth and biologic properties of karyotypically defined subcategories of adult acute lymphocytic leukemia in mice with severe combined immunodeficiency.
Jeha S; Kantarjian H; O'Brien S; Huh Y; Pisa P; Ordonez N; Beran M
Blood; 1995 Dec; 86(11):4278-85. PubMed ID: 7492788
[TBL] [Abstract][Full Text] [Related]
14. A model of human acute lymphoblastic leukemia in immune-deficient SCID mice.
Kamel-Reid S; Letarte M; Sirard C; Doedens M; Grunberger T; Fulop G; Freedman MH; Phillips RA; Dick JE
Science; 1989 Dec; 246(4937):1597-600. PubMed ID: 2595371
[TBL] [Abstract][Full Text] [Related]
15. Distinct in vivo engraftment and growth patterns of t(1;19)+/E2A-PBX1+ and t(9;22)+/BCR-ABL+ human leukemia cells in SCID mice.
Waurzyniak BJ; Heerema N; Sensel MG; Gaynon PS; Kraft P; Sather HN; Chelstrom L; Reaman GH; Uckun FM
Leuk Lymphoma; 1998 Dec; 32(1-2):77-87. PubMed ID: 10037003
[TBL] [Abstract][Full Text] [Related]
16. Monitoring of engraftment and progression of acute lymphoblastic leukemia in individual NOD/SCID mice.
Nijmeijer BA; Mollevanger P; van Zelderen-Bhola SL; Kluin-Nelemans HC; Willemze R; Falkenburg JH
Exp Hematol; 2001 Mar; 29(3):322-9. PubMed ID: 11274760
[TBL] [Abstract][Full Text] [Related]
17. Growth of human T-cell lineage acute leukemia in severe combined immunodeficiency (SCID) mice and non-obese diabetic SCID mice.
Steele JP; Clutterbuck RD; Powles RL; Mitchell PL; Horton C; Morilla R; Catovsky D; Millar JL
Blood; 1997 Sep; 90(5):2015-9. PubMed ID: 9292537
[TBL] [Abstract][Full Text] [Related]
18. IMC-EB10, an anti-FLT3 monoclonal antibody, prolongs survival and reduces nonobese diabetic/severe combined immunodeficient engraftment of some acute lymphoblastic leukemia cell lines and primary leukemic samples.
Piloto O; Nguyen B; Huso D; Kim KT; Li Y; Witte L; Hicklin DJ; Brown P; Small D
Cancer Res; 2006 May; 66(9):4843-51. PubMed ID: 16651440
[TBL] [Abstract][Full Text] [Related]
19. Biologic and cytogenetic characteristics of leukemia in infants.
Stark B; Vogel R; Cohen IJ; Umiel T; Mammon Z; Rechavi G; Kaplinsky C; Potaznik D; Dvir A; Yaniv Y
Cancer; 1989 Jan; 63(1):117-25. PubMed ID: 2910409
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
